CompareMarketResearchRequest a sample
Home / Healthcare / Multi-Organ Transplant Monitoring

Healthcare · Market report

Multi-Organ Transplant Monitoring Market Size, Share and Forecast 2026-2036

The global multi-organ transplant monitoring market is worth USD 1.1 bn in 2026 and is forecast to reach USD 2.5 bn by 2036, growing at a 9.0% CAGR. United States is the largest country market and Donor-derived cell-free DNA is the largest by test segment.

USD 1.1 bnMarket size 2026
USD 2.5 bnForecast 2036
9.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global multi-organ transplant monitoring market is worth USD 1.1 bn in 2026 and is forecast to reach USD 2.5 bn by 2036, growing at a 9.0% CAGR. United States is the largest country market and Donor-derived cell-free DNA is the largest by test segment.

ScopeTests used to watch for rejection and infection after solid organ transplants: donor-derived cell-free DNA, gene-expression profiles, viral load tests for CMV, BK and EBV, and immune function assays.
IndustryHealthcare
Value 2025USD 980 mn
Value 2026USD 1.1 bn
Value 2036USD 2.5 bn
CAGR 2026-20369.0%
Volume 20262,071 thousand tests
Volume 20364,903 thousand tests
Average price 2026USD 516 per test
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Multi-Organ Transplant Monitoring market size and forecast, 2026-2036

Exhibit 1The global multi-organ transplant monitoring market is forecast to grow from USD 1.1 bn in 2026 to USD 2.5 bn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 9.0%
Multi-Organ Transplant Monitoring market value, 2025 to 2036Market value by year. 2025: USD 980 mn; 2026: USD 1.1 bn; 2027: USD 1.2 bn; 2028: USD 1.3 bn; 2029: USD 1.4 bn; 2030: USD 1.5 bn; 2031: USD 1.6 bn; 2032: USD 1.8 bn; 2033: USD 2.0 bn; 2034: USD 2.1 bn; 2035: USD 2.3 bn; 2036: USD 2.5 bn. Compound annual growth rate 2026 to 2036: 9.0%.20251.1 bn20261.6 bn20312.5 bn20369.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 1.1 bn
2027USD 1.2 bn
2028USD 1.3 bn
2029USD 1.4 bn
2030USD 1.5 bn
2031USD 1.6 bn
2032USD 1.8 bn
2033USD 2.0 bn
2034USD 2.1 bn
2035USD 2.3 bn
2036USD 2.5 bn

Multi-Organ Transplant Monitoring market segmentation

By test

Exhibit 2Donor-derived cell-free DNA is the largest segment by test, with 43.0% of 2026 revenueEstimated share of 2026 global revenue, by test
Multi-Organ Transplant Monitoring market share by test, 2026Share of 2026 revenue by test. Donor-derived cell-free DNA: 43.0%; Viral load monitoring: 33.0%; Immune function and biomarker assays: 16.0%; Gene-expression profiling: 8.0%.Donor-derived cell-free DNA43.0%Viral load monitoring33.0%Immune function and biomarker assays16.0%Gene-expression profiling8.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Donor-derived cell-free DNA43.0%46.3%USD 459 mn9.8%
Viral load monitoring33.0%28.3%USD 353 mn7.3%
Immune function and biomarker assays16.0%18.9%USD 171 mn10.8%
Gene-expression profiling8.0%6.5%USD 85 mn6.8%

By organ

Exhibit 3Kidney adds the most revenue by organ, growing from USD 555 mn in 2026 to USD 1.3 bn by 2036Estimated revenue in USD by organ, 2026 and 2036 forecast
Multi-Organ Transplant Monitoring market by organ, 2026 and 2036Revenue by organ in 2026 and 2036. Kidney: USD 555 mn in 2026, USD 1.3 bn in 2036, change +135%; Heart: USD 192 mn in 2026, USD 472 mn in 2036, change +146%; Lung: USD 128 mn in 2026, USD 329 mn in 2036, change +157%; Liver: USD 128 mn in 2026, USD 287 mn in 2036, change +124%; Other organs: USD 64 mn in 2026, USD 137 mn in 2036, change +114%.20262036 forecastChangeKidney+135%555 mn1.3 bnHeart+146%192 mn472 mnLung+157%128 mn329 mnLiver+124%128 mn287 mnOther organs+114%64 mn137 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Kidney52.0%51.5%USD 555 mn8.9%
Heart18.0%18.7%USD 192 mn9.4%
Lung12.0%13.0%USD 128 mn9.9%
Liver12.0%11.4%USD 128 mn8.4%
Other organs6.0%5.4%USD 64 mn7.9%

By technology

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Donor-derived cell-free DNA36.0%38.0%USD 385 mn9.6%
Gene expression profiling28.0%29.0%USD 299 mn9.4%
Immunoassays and biochemistry22.0%19.0%USD 235 mn7.4%
Microbiome and viral monitoring14.0%14.0%USD 150 mn9.0%

By end user

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Transplant centers52.0%48.0%USD 555 mn8.1%
Reference laboratories30.0%31.0%USD 320 mn9.4%
Home and decentralized monitoring18.0%21.0%USD 192 mn10.7%

By monitoring phase

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Pre-transplant matching18.0%16.0%USD 192 mn7.7%
Early post-transplant34.0%32.0%USD 363 mn8.3%
Long-term surveillance48.0%52.0%USD 513 mn9.9%

Top 25 countries for multi-organ transplant monitoring by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 92.0% of 2026 revenue and the 25 countries below together hold 97.8%.

Exhibit 4United States is the largest country market at USD 620 mn in 2026, and the three largest countries hold 69.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Multi-Organ Transplant Monitoring market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 620 mn, 58.0%; Germany: USD 64 mn, 6.0%; United Kingdom: USD 53 mn, 5.0%; France: USD 53 mn, 5.0%; Japan: USD 43 mn, 4.0%; Canada: USD 32 mn, 3.0%; Australia: USD 32 mn, 3.0%; Spain: USD 32 mn, 3.0%; Italy: USD 32 mn, 3.0%; Brazil: USD 21 mn, 2.0%.United States620 mn 58.0%Germany64 mn 6.0%United Kingdom53 mn 5.0%France53 mn 5.0%Japan43 mn 4.0%Canada32 mn 3.0%Australia32 mn 3.0%Spain32 mn 3.0%Italy32 mn 3.0%Brazil21 mn 2.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 620 mn58.0%USD 1.5 bn9.3%
2GermanyUSD 64 mn6.0%USD 142 mn8.2%
3United KingdomUSD 53 mn5.0%USD 124 mn8.8%
4FranceUSD 53 mn5.0%USD 119 mn8.3%
5JapanUSD 43 mn4.0%USD 91 mn7.9%
6CanadaUSD 32 mn3.0%USD 73 mn8.6%
7AustraliaUSD 32 mn3.0%USD 78 mn9.4%
8SpainUSD 32 mn3.0%USD 71 mn8.2%
9ItalyUSD 32 mn3.0%USD 68 mn7.9%
10BrazilUSD 21 mn2.0%USD 56 mn10.0%
11NetherlandsUSD 12 mn1.1%USD 28 mn9.2%
12South KoreaUSD 9.2 mn0.9%USD 22 mn9.2%
13BelgiumUSD 7.9 mn0.7%USD 19 mn9.3%
14SwitzerlandUSD 6.3 mn0.6%USD 15 mn9.4%
15AustriaUSD 5.5 mn0.5%USD 13 mn9.2%
16SwedenUSD 4.4 mn0.4%USD 11 mn9.3%
17DenmarkUSD 3.5 mn0.3%USD 8.3 mn9.0%
18MexicoUSD 2.9 mn0.3%USD 7.1 mn9.4%
19IsraelUSD 2.4 mn0.2%USD 5.8 mn9.5%
20PolandUSD 2.0 mn0.2%USD 4.8 mn9.0%
21TurkeyUSD 1.6 mn0.1%USD 4.0 mn9.7%
22NorwayUSD 1.4 mn0.1%USD 3.3 mn9.0%
23IndiaUSD 1.2 mn0.1%USD 3.0 mn9.9%
24ArgentinaUSD 0.96 mn0.09%USD 2.3 mn9.0%
25Saudi ArabiaUSD 0.85 mn0.08%USD 2.0 mn9.0%
Rest of worldUSD 24 mn2.2%USD 56 mn8.8%
Exhibit 5United States and Germany account for 66% of the USD 1.5 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Multi-Organ Transplant Monitoring market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 1.1 bn. United States: +USD 883 mn; Germany: +USD 78 mn; United Kingdom: +USD 70 mn; France: +USD 65 mn; Japan: +USD 48 mn; 20 other countries: +USD 285 mn; Rest of world: +USD 32 mn. Market value 2036: USD 2.5 bn.Market value 20261.1 bnUnited States+883 mnGermany+78 mnUnited Kingdom+70 mnFrance+65 mnJapan+48 mn20 other countries+285 mnRest of world+32 mnMarket value 20362.5 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • CareDx
  • Natera
  • Roche Diagnostics
  • Abbott
  • Thermo Fisher Scientific

Group 2: Regional and specialist players

  • Eurofins Viracor
  • Qiagen
  • Immucor
  • DiaSorin
  • Hologic

Group 3: Emerging and niche players

  • Verici Dx
  • Oncocyte
  • GenDx
  • Omixon
  • Chronix Biomedical

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the multi-organ transplant monitoring market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 9.0% is calculated from the resulting values.

The market is divided by test, by organ, by technology, by end user, by monitoring phase. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the multi-organ transplant monitoring market?

The global multi-organ transplant monitoring market is estimated at USD 980 mn in 2025 and USD 1.1 bn in 2026.

How fast will the multi-organ transplant monitoring market grow?

It is forecast to reach USD 2.5 bn by 2036, a compound annual growth rate of 9.0% from 2026, an increase of USD 1.5 bn.

Which country is the largest market for multi-organ transplant monitoring?

United States is the largest market by revenue at USD 620 mn in 2026, 58.0% of the global total. The three largest countries together hold 69.0%.

Which country is growing fastest?

Among the ten largest markets, Brazil is growing fastest at 10.0% a year from 2026 to 2036.

Which multi-organ transplant monitoring segment is largest?

In the by test split, Donor-derived cell-free DNA is the largest segment with 43.0% of 2026 revenue.

Who are the leading multi-organ transplant monitoring companies?

Global leaders include CareDx, Natera, Roche Diagnostics, Abbott.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Monoclonal Antibodies Multiplex Sepsis Biomarker Panels →

All Healthcare markets →

Request a sample